Rua Bioscience

Rua Bioscience FCF per Share

The Free Cash Flow per Share of Rua Bioscience (RUA.NZ) as of Oct 19, 2026 is -0.01 NZD. In the previous year, Free Cash Flow per Share was -0.02 NZD — a change of -28.26% (higher).

FCF per Share

-0.01NZD

YoY

-28.26%

Last updated:

Free Cash Flow per Share of Rua Bioscience is 2025 -0.01 NZD. Free Cash Flow per Share of Rua Bioscience was 2024 -0.02 NZD. It decreases by -28.26% higher compared to the previous year.

The Rua Bioscience FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2019
-0.02 NZD
Jan 1, 2020
-0.06 NZD
Jan 1, 2021
-0.05 NZD
Jan 1, 2022
-0.04 NZD
Jan 1, 2023
-0.03 NZD
Jan 1, 2024
-0.02 NZD
Jan 1, 2025
-0.01 NZD
The Rua Bioscience FCF per Share history
YEARFCF per ShareYoY
-0.01NZD-28.26%
-0.02NZD-39.43%
-0.03NZD-24.49%
-0.04NZD-7.39%
-0.05NZD-25.66%
-0.06NZD+259.26%
-0.02NZD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rua Bioscience Stock analysis

What does Rua Bioscience do? Rua Bioscience Ltd, trading as RUA.NZ, is a pharmaceutical company headquartered in Gisborne, New Zealand. The company operates in the Health Care sector, specifically within Pharmaceuticals. It conducts research and development, and engages in pharmaceutical distribution and marketing. Rua Bioscience focuses on breeding, cultivating, manufacturing, and supplying medicinal cannabis products. The firm operates through one segment, offering research and development services and pharmaceutical products in Germany and New Zealand. It maintains a full research laboratory in Gisborne for cannabinoid testing, microscopic analysis, moisture analysis, sample preparation, extraction, solvent removal, viscosity measurements, and impurity testing. The company completed its IPO on October 22, 2020. Rua Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rua Bioscience stock

Free Cash Flow per Share of Rua Bioscience is -0.01 NZD in 2025.

Free Cash Flow per Share of Rua Bioscience changed from -0.02 NZD to -0.01 NZD, representing a -28.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Rua Bioscience since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Rua Bioscience

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Rua Bioscience